These findings demonstrate that STING agonists have antiviral effects in IFV infection of the human nasal epithelium and highlight the potential of STING agonists to be developed as a safe and effective drug to prevent and treat infections with respiratory pathogens. This evidence concerns the gene STING1 and infection.